BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10558902)

  • 1. NAD(+) consumption in carcinogen-treated hamster cells overexpressing a dominant negative mutant of poly(ADP-ribose) polymerase.
    Küpper JH; Müller M; Wolf I
    Biochem Biophys Res Commun; 1999 Nov; 265(2):525-9. PubMed ID: 10558902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-dominant inhibition of poly(ADP-ribosyl)ation potentiates carcinogen induced gene amplification in SV40-transformed Chinese hamster cells.
    Kupper JH; Müller M; Bürkle A
    Cancer Res; 1996 Jun; 56(12):2715-7. PubMed ID: 8665500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
    Gao H; Coyle DL; Meyer-Ficca ML; Meyer RG; Jacobson EL; Wang ZQ; Jacobson MK
    Exp Cell Res; 2007 Mar; 313(5):984-96. PubMed ID: 17276427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells.
    Weidele K; Kunzmann A; Schmitz M; Beneke S; Bürkle A
    Biochem Pharmacol; 2010 Oct; 80(7):1103-12. PubMed ID: 20599792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
    Kumari SR; Mendoza-Alvarez H; Alvarez-Gonzalez R
    Cancer Res; 1998 Nov; 58(22):5075-8. PubMed ID: 9823314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribosyl)ation: its role in inducible DNA amplification, and its correlation with the longevity of mammalian species.
    Bürkle A; Grube K; Küpper JH
    Exp Clin Immunogenet; 1992; 9(4):230-40. PubMed ID: 1307244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. trans-dominant inhibition of poly(ADP-ribosyl)ation sensitizes cells against gamma-irradiation and N-methyl-N'-nitro-N-nitrosoguanidine but does not limit DNA replication of a polyomavirus replicon.
    Küpper JH; Müller M; Jacobson MK; Tatsumi-Miyajima J; Coyle DL; Jacobson EL; Bürkle A
    Mol Cell Biol; 1995 Jun; 15(6):3154-63. PubMed ID: 7760811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair.
    Oei SL; Shi Y
    Biochem Biophys Res Commun; 2001 Jun; 284(2):450-4. PubMed ID: 11394900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage.
    Affar el B; Shah RG; Dallaire AK; Castonguay V; Shah GM
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):245-50. PubMed ID: 11756665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis.
    Rosenthal DS; Ding R; Simbulan-Rosenthal CM; Vaillancourt JP; Nicholson DW; Smulson M
    Exp Cell Res; 1997 May; 232(2):313-21. PubMed ID: 9168807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo.
    Hans MA; Müller M; Meyer-Ficca M; Bürkle A; Küpper JH
    Oncogene; 1999 Nov; 18(50):7010-5. PubMed ID: 10597301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
    Sukhanova MV; Lavrik OI; Khodyreva SN
    Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a poly(ADP-ribose) polymerase inhibitor on DNA breakage and cytotoxicity induced by hydrogen peroxide and gamma-radiation.
    Cristóvão L; Rueff J
    Teratog Carcinog Mutagen; 1996; 16(4):219-27. PubMed ID: 9381409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for prostate cancer by targeting poly(ADP-ribose) polymerase.
    Trofimova I; Dimtchev A; Jung M; Rosenthal D; Smulson M; Dritschilo A; Soldatenkov V
    Cancer Res; 2002 Dec; 62(23):6879-83. PubMed ID: 12460902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage.
    Schreiber V; Hunting D; Trucco C; Gowans B; Grunwald D; De Murcia G; De Murcia JM
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4753-7. PubMed ID: 7761396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis.
    Nosseri C; Coppola S; Ghibelli L
    Exp Cell Res; 1994 Jun; 212(2):367-73. PubMed ID: 8187831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mono- and poly(ADP-ribose) metabolism following DNA damage.
    Jacobson MK; Smith JY; Mingmuang M; Payne DM; Jacobson EL
    Princess Takamatsu Symp; 1983; 13():165-74. PubMed ID: 6317635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-selegiline potentiates the cellular poly(ADP-ribosyl)ation response to ionizing radiation.
    Brabeck C; Pfeiffer R; Leake A; Beneke S; Meyer R; Burkle A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):973-9. PubMed ID: 12750436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.